Virpax Pharmaceuticals Inc. (VRPX:OTC) closed at $0.001 on October 22, 2026, unchanged on the day. The stock trades 99.2% below its 52-week high of $0.100 and 700.0% above its 52-week low of $0.000. Virpax Pharmaceuticals Inc. is part of the Health Care sector.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Find more stocks like VRPX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.